CA 125 Test Market Comprehensive Analysis and Future Estimations 2023 with Trends and Future Prospects Details for Business Development by MRFR

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “CA 125 Test Market Research Report – Global Forecast Till 2023” Gives industry size, top players and worldwide demand

Market Synopsis of the Global CA 125 Test Market

Cancer Antigen (CA) test is used to diagnose various disease such as cancer, uterine fibroids, endometriosis, and liver disease. CA 125 is a protein that is found in the blood. The test is mostly widely used of the diagnosis of ovarian cancer in women. Normal levels of CA 125 in the blood is less 30 units per ml. and elevated levels for CA 125 signals the presence cancer in the ovary. Besides diagnosis, the CA 125 test is also used for monitoring ovarian cancer, as well as for screening ovarian cancer in women suspected to be at high risk for developing the disease.

Increasing demand for cancer diagnosis and treatment services, rising prevalence of cancer among the women and increasing emphasis on women healthcare. Furthermore, extensive diagnostic tests for cancer, also fuel the market growth. The growth of the market is restrained by the high cost of devices used in cancer diagnostics.

Get Sample Copy @

According to the American Cancer Society, in 2015, ovarian cancer represents only 3% of all malignancies in the U.S. women. Also there is a rise in the death rate due to various types of cancer of reproductive tract in women. Additionally, in the U.S., 22,280 women were estimated to have received an ovarian cancer diagnostic services and 14,240 deaths.

The global CA 125 test market is blooming and is expected to grow at a CAGR of 5.7% during the forecast period.


The global CA 125 test market is segmented on the basis of devices and accessories, devices, and end user.

On the basis of devices and accessories, market is segmented into spectrometer, analyzer, sample collection tubes, isotopic labeled peptides, and others.

On the basis of indication, the market is segmented into cancer, uterine fibroids, endometriosis, liver diseases, and others. Cancer is further segmented into ovarian cancer, endometrial cancer, fallopian tube cancer, stomach cancer, breast cancer, and others.

On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, and others.

Regional Analysis of the Global CA 125 Test Market                

America holds the first position in the market for CA 125 test owing to the rising prevalence of ovarian cancer in the U.S. and Canada. Additionally, the availability of a wide range of diagnosis and treatment methods for cancer and technological advancement in the field of oncology, also support the growth of the market in American countries. Presence of key player in the market also accelerates the growth of the market. These players are engaged in various strategic approaches such as mergers, acquisition, collaborations, partnership, and research activities, leading to the development of the market in North America.

In Europe, the market shows extensive growth owing to extensive research and development activities, and increasing demand for new medical devices for diagnosis of cancer drive the growth of the market. Germany, U.K, and France acquire first, second and third place respectively, in the European CA 125 test market.

The market in Asia Pacific is expected to grow at the fastest pace whose market is driven rising awareness about reproductive health and diseases among women, and improving healthcare infrastructure. Availability of highly qualified healthcare professionals such as physicians, surgeons and gynecologist in the developing regions such as India, Japan and China further fuel the market.

The Middle East & Africa also show a steady rise in the market owing to low prevalence of ovarian cancer, rising demand for diagnostic services and growing emphasis on diagnosis and treatment of cancer disease. Developing healthcare infrastructure in the Middle East also fuels the growth of the market. In the Middle East & Africa, the Middle East accounts for the largest market share owing to the availability of better healthcare services in the Middle East countries than in Africa.

Key Players in the Global CA 125 Test Market 

Some of the key players in this market are Allergan plc. (U.K), Amgen Inc. (U.S.), Bayer (Germany), BD (U.S.), Eli Lilly Company (U.S.) , Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Private Limited (Israel), AMAG Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Sanofi (France), Novartis (Germany), AbbVie Inc. (U.S.), GlaxoSmithKline plc. (U.S.), and others.

Apply for Exclusive Discount @  

Detailed Table of Contents:

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation


Table 1 CA 125 Test Industry Synopsis, 2017-2023

Table 2 Global CA 125 Test Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3 Global CA 125 Test Market By Region, 2017-2023, (USD Million)

Table 4 Global CA 125 Test Market By Devices And Accessories, 2017-2023, (USD Million)

Table 5 Global CA 125 Test Market By Indication, 2017-2023, (USD Million)

Table 6 Global CA 125 Test Market By End Users, 2017-2023, (USD Million)

Table 7 North America CA 125 Test Market By Devices And Accessories, 2017-2023, (USD Million)


Figure 1 Research Process

Figure 2 Segmentation For Global CA 125 Test Market

Figure 3 Segmentation Market Dynamics For CA 125 Test Market

Figure 4 Global CA 125 Test Market Share, By Devices And Accessories, 2016

Figure 5 Global CA 125 Test Market Share, By Indication, 2016

Figure 6 Global CA 125 Test Market Share, By End Users, 2016

Figure 7 Global CA 125 Test Market Share, By Region, 2016



Send An Enquiry @  


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India